Our earlier studies indicated that sulforaphane decreased glycolytic metabolism in a hypoxia microenvironment by inhibiting hypoxia-induced HIF-1α and HIF-1α trans-localization in non-muscle-invasive bladder cancer cell lines [16]. Here, HIF1A is linked to urinary bladder cancer.